Cutivate
Cutivate is a medicine authorised by Swissmedic under authorisation number 52381. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 June 1994 and the authorisation is valid without a time limit. ATC code D07AC17 places the medicine in the group Corticosteroids, dermatological preparations.
| Authorisation number | 52381 |
|---|---|
| Name | Cutivate |
| Full name | Cutivate, Salbe |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D07AC17 |
| First authorisation | 13 June 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cutivate, Salbe | B | 13 June 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | g | D07AC17 | 10.05.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cutivate authorised in Switzerland?
Yes. Cutivate is authorised by Swissmedic under authorisation number 52381, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cutivate have?
Cutivate is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cutivate?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.